Hydrocodone/aspirin
| Combination of | |
|---|---|
| Hydrocodone | Opioid analgesic |
| Aspirin | NSAIDTooltip nonsteroidal anti-inflammatory drug |
| Clinical data | |
| Trade names | Alor 5/500, Azdone, Damason-P, Lortab ASA, Panasal 5/500 |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
Hydrocodone/aspirin (INNs) is an oral combination drug formulation of the opioid analgesic hydrocodone and the nonsteroidal anti-inflammatory drug (NSAID) aspirin that is used in the treatment of chronic and acute pain.[1] It is sold under brand names including Alor 5/500, Azdone, Damason-P, Lortab ASA, and Panasal 5/500.
Adverse effects
See also: Aspirin § Adverse effects, and Hydrocodone § Adverse effects
See also
References
- ↑ Odom-Forren J, Drain C (11 February 2008). PeriAnesthesia Nursing: A Critical Care Approach. Elsevier Health Sciences. pp. 751–. ISBN 978-1-4377-2610-7.
Opioid receptor modulators | |||||
|---|---|---|---|---|---|
| μ-opioid (MOR) |
| ||||
| δ-opioid (DOR) |
| ||||
| κ-opioid (KOR) |
| ||||
| Nociceptin (NOP) |
| ||||
| Others |
| ||||
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.